LAPTM5 exacerbates STING-mediated inflammation induced by LL-37 through stabilizing STING in rosacea

Wenyue Huang(Xi'an Jiaotong University), Yan Wu(Guangzhou University of Chinese Medicine), Shulan Yao(Affiliated Hospital of Jining Medical University), Yi Jiang(First Hospital of China Medical University), Hailun He(Third People's Hospital of Chengdu), Linlin Zhu(Seventh People's Hospital of Shanghai), Yan Sun(Peking University), Jingyu Wang(First Hospital of China Medical University), Haien Wu(Seventh People's Hospital of Shanghai), Yichong Wang(Emory National Primate Research Center), Xinze Cai(First Hospital of China Medical University), Hexiao Wang(Memorial Sloan Kettering Cancer Center)
Communications Biology
October 14, 2025
10.1038/s42003-025-08861-8
Cited by 2

Related Papers

Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial
|The Lancet|2008|1.2k
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
|New England Journal of Medicine|2019|934
The P300 and reward valence, magnitude, and expectancy in outcome evaluation
|Brain Research|2009|474
The amino acid sensor GCN2 controls gut inflammation by inhibiting inflammasome activation
|Nature|2016|306
Updating the diagnosis, classification and assessment of rosacea: recommendations from the global <scp>ROS</scp> acea <scp>CO</scp> nsensus ( <scp>ROSCO</scp> ) panel
|British Journal of Dermatology|2016|287